111 related articles for article (PubMed ID: 11363995)
1. HCG: new kind of KS treatment?
James JS
AIDS Treat News; 1996 Nov; (No 258):1-3. PubMed ID: 11363995
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
3. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries.
Bisacchi D; Noonan DM; Carlone S; Albini A; Pfeffer U
Biol Chem; 2002 Sep; 383(9):1315-20. PubMed ID: 12437123
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Kaposi's sarcoma with human chorionic gonadotropin.
Simonart T; Van Vooren JP; Meuris S
Dermatology; 2002; 204(4):330-3. PubMed ID: 12077540
[TBL] [Abstract][Full Text] [Related]
6. Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: is there a connection?
Butler SA; Iles RK
Clin Cancer Res; 2003 Oct; 9(13):4666-73. PubMed ID: 14581335
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin.
Lang ME; Lottersberger C; Roth B; Böck G; Recheis H; Sgonc R; Stürzl M; Albini A; Tschachler E; Zangerle R; Donini S; Feichtinger H; Schwarz S
AIDS; 1997 Sep; 11(11):1333-40. PubMed ID: 9302442
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin.
Harris PJ
Lancet; 1995 Jul; 346(8967):118-9. PubMed ID: 7603190
[No Abstract] [Full Text] [Related]
9. Human chorionic gonadotropin for AIDS-related Kaposi's sarcoma.
Bower M; Fife K; Nelson M; Youle M
Lancet; 1995 Sep; 346(8975):642. PubMed ID: 7651033
[No Abstract] [Full Text] [Related]
10. Human chronic gonadotropin for AIDS-related Kaposi's sarcoma.
von Overbeck J; Perey L; Iten A; Pechère M; Ruffieux P; Hirschel B
Lancet; 1995 Sep; 346(8975):642-3. PubMed ID: 7651034
[No Abstract] [Full Text] [Related]
11. Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth.
Pfeffer U; Bisacchi D; Morini M; Benelli R; Minghelli S; Vacca A; Noonan DM; Albini A
Endocrinology; 2002 Aug; 143(8):3114-21. PubMed ID: 12130577
[TBL] [Abstract][Full Text] [Related]
12. Debunking hCG.
Sairam MR; Antakly T
Nat Biotechnol; 1997 Nov; 15(12):1228. PubMed ID: 9359097
[No Abstract] [Full Text] [Related]
13. Human chorionic gonadtropin.
Smart T
GMHC Treat Issues; 1995; 9(7/8):15. PubMed ID: 11362654
[TBL] [Abstract][Full Text] [Related]
14. A synthetic peptide derived from the human eosinophil-derived neurotoxin induces apoptosis in Kaposi's sarcoma cells.
Dricu A; Sergiu-Bogdan C; Brismar K; Biberfeld P; Andersson LC
Anticancer Res; 2004; 24(3a):1427-32. PubMed ID: 15274305
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of Kaposi's sarcoma cell growth by urine from women in early pregnancy, the current source for clinical-grade human chorionic gonadotropin preparations.
Simonart T; Hermans P; Delogne-Desnoeck J; Van Vooren JP; Meuris S
Exp Dermatol; 2002 Aug; 11(4):365-9. PubMed ID: 12190946
[TBL] [Abstract][Full Text] [Related]
16. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin.
Samaniego F; Bryant JL; Liu N; Karp JE; Sabichi AL; Thierry A; Lunardi-Iskandar Y; Gallo RC
J Natl Cancer Inst; 1999 Jan; 91(2):135-43. PubMed ID: 9923854
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
18. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
19. KS drug goes to FDA. Food and Drug Administration.
GMHC Treat Issues; 1998 May; 12(5):7. PubMed ID: 11365479
[TBL] [Abstract][Full Text] [Related]
20. New approaches to HIV treatment: interview with Robert Gallo. M.D. Interview by John S. James.
Gallo RC
AIDS Treat News; 1997 Dec; (No 285):1-5. PubMed ID: 11364917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
